CI
NVET

Cowen Inc’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Cowen Inc’s Portfolio NVET Stock Details NVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,542
Closed -$43K – 344
2016
Q4 		$43K Sell
11,542
-3,100
-21% -$12.8K ﹤0.01% 237
2016
Q3 		$61K Sell
14,642
-12,843
-47% -$60.9K ﹤0.01% 223
2016
Q2 		$128K Hold
27,485
– – 0.01% 194
2016
Q1 		$91K Hold
27,485
– – ﹤0.01% 236
2015
Q4 		$94K Hold
27,485
– – 0.01% 280
2015
Q3 		$100K Sell
27,485
-5,000
-15% -$22.8K 0.01% 227
2015
Q2 		$161K Buy
+32,485
New +$225K 0.01% 392

Other funds holding NVET

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
LLC
Latimer Light Capital New York $432M AUM 25.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cowen Inc's NVET Position: Q1 2017 in Review

Cowen Inc sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q1 2017, closing a stake of 11,542 shares — an estimated $43K sold.

Cowen Inc first reported a position in NVET in Q2 2015 and held it in 7 quarters. The position peaked at $161K in Q2 2015. 13 funds tracked by Wall St. Rank hold NVET as of Q1 2017.

  • Cowen Inc reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q1 2017 after selling out during the quarter.
  • Cowen Inc sold 11,542 Nexvet Biopharma plc Ordinary Shares shares in Q1 2017, an estimated $43K.
  • Cowen Inc first reported a position in Nexvet Biopharma plc Ordinary Shares in Q2 2015 and held it in 7 quarters.
  • Cowen Inc's Nexvet Biopharma plc Ordinary Shares position peaked at $161K in Q2 2015.
  • 13 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q1 2017.

Based on Cowen Inc's 13F filing for Q1 2017, filed 12 May 2017.